ATC Group: R03BA01 Beclometasone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03BA01 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03B Other drugs for obstructive airway diseases, inhalants
4 R03BA Glucocorticoids
5 R03BA01 Beclometasone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
RESPIR - Respiratory (Inhalation) (aerosol) 0.8 mg
RESPIR - Respiratory (Inhalation) (powder) 0.8 mg
RESPIR - Respiratory (Inhalation) (solution) 1.5 mg

Active ingredients in R03BA01

Active Ingredient Description
Beclometasone

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.

Related product monographs

Title Information Source Document Type  
BECLATE Nasal spray Health Products Regulatory Authority (ZA) MPI, Generic
BECLAZONE 100mg Pressurised inhalation, solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
BECLAZONE 250mg Pressurised inhalation, solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
BECOTIDE EVOHALER Pressurised inhalation, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
CLENIL FORTE SPRAY Pressurised inhalation solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
CLENIL Pressurised inhalation solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
QVAR MDI Pressurised inhalation, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SOPROBEC Pressurised inhalation solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.